Prostamide F2αreceptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibition
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostamide F2αreceptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibition
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 171, Issue 6, Pages 1408-1419
Publisher
Wiley
Online
2013-10-08
DOI
10.1111/bph.12410
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Concise Guide to PHARMACOLOGY 2013/14: Overview
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anandamide-derived Prostamide F2αNegatively Regulates Adipogenesis
- (2013) Cristoforo Silvestri et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
- (2013) Daniel J Hermanson et al. NATURE NEUROSCIENCE
- Endocannabinoids: A unique opportunity to develop multitarget analgesics
- (2013) Sabatino Maione et al. PAIN
- The Endocannabinoid System and Pain
- (2012) Josee Guindon et al. CNS & Neurological Disorders-Drug Targets
- Discovery of Prostamide F2α and Its Role in Inflammatory Pain and Dorsal Horn Nociceptive Neuron Hyperexcitability
- (2012) Luisa Gatta et al. PLoS One
- (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2
- (2011) Kelsey C Duggan et al. Nature Chemical Biology
- International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress
- (2011) D. F. Woodward et al. PHARMACOLOGICAL REVIEWS
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice
- (2010) Francesca Comelli et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB1 receptor antagonist
- (2010) Jenny L. Wiley et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Prostanoid receptor antagonists: development strategies and therapeutic applications
- (2009) RL Jones et al. BRITISH JOURNAL OF PHARMACOLOGY
- Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo
- (2008) Tiziana Bisogno et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes
- (2008) Y Liang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFκB activity
- (2008) S Shu-Jung Hu et al. BRITISH JOURNAL OF PHARMACOLOGY
- The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products
- (2008) D.F. Woodward et al. PHARMACOLOGY & THERAPEUTICS
- Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain
- (2007) M D Jhaveri et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search